The stool-DNA screening is one of the first tests accessible in trading and clinically confirmed to be used for the analysis of hypermethylated vimentin gene to be able to detect CRC (ColoSureÔ, Laboratory Corp, Burlington, North Carolina, United States). The gene discussed is VIM; the disease is colorectal carcinoma.